The metabolic syndrome: How to approach differing definitions

Obesity Management

Volumn 2, Issue 2, 2006, Pages 58-62

  Pi Sunyer, F Xavier ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b St Luke's Roosevelt Hospital Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL PRACTICE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR;

EID: 33744479170     PISSN: 15451712     EISSN: None     Source Type: Journal    
DOI: 10.1089/obe.2006.2.58     Document Type: Review

References (39)

1. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal. Diabetes Care. 2005;28:2289-2304.
2. Expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (2001); Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:22486-2497.
3. Report of a WHO Consultation. In: Alwan A, King, H, eds. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance; 1999:1-59.
4. Balkau B, Charles MA, Drivsholm T, et. al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. European Group For the Study of Insulin Resistance (EGIR). Diabetes Metab. 2002;28:364-376.
5. Einhorn D, Reaven GM, Cobin RH, et. al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-252.
6. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
7. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438.
8. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome: A new worldwide definition. Lancet. 2005;366:1059-1062.
9. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-58.
10. National Center for Health Statistics: Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, MD, National Center for Health Statistics, 1994 (Vital and Health Statistics Series 1, no. 32).
11. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
12. Stern M, Williams K, Gonzalez-Villapando C, et. al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-419.
13. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes. Arch Int Med. 2005;165:2644-2650.
14. Edelstein SL, Knowler WC, Bain RP, et. al. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes. 1997;46:701-710.
15. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
16. Kuusisto J, Lempainen P, Mikkanen L, Laakso M. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care. 2001;24:683-689.
17. Onat A, Ceyhan K, Basar O, et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: A prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285-292.
18. Lampiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 1999;100:123-128.
19. Kekalainen P, Sarlund H, Pyorala K, Laakso M. Hyperinsulinemia cluster predicts the development of type 2 diabetes independent of a family history of diabetes. Diabetes Care. 1999;22:86-92.
20. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 2000;20:538-544.
21. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP metabolic syndrome, diabetes mellitus and prevalence of coronary heart disease. Diabetes. 2003;52:1210-1214.
22. Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Int Med. 2004;164:1092-1097.
23. Griman CJ. Rhodes T, Mercuri M. et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 2004;93:136-141.
24. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and on all causes in United States adults. Circulation. 2004;110:1245-1250.
25. Scuteri A, Najjar S, Morrell C, Lakatta F. The metabolic syndrome in older individuals: Prevalence and prediction of cardiovascular events. Diabetes Care. 2005;28:882-887.
26. Bruno G, Merletti F, Biggeri A, et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: The Casale Montferrato Study. Diabetes Care. 2004;27:2689-2694.
27. Resnick Hem Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in non-diabetic American Indians: The Strong Heart Study. Diabetes Care. 2003;26:861-867.
28. Marroquin OC, Kip KE, Kelley DE, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the Women's Ischemia Syndrome Evaluation. Circulation. 2004;109:714-721.
29. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kampusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;88:2709-2716.
30. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National cholesterol education program versus world health organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004;11:1251-1257.
31. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385-390.
32. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:424-419.
33. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25:1790-1794.
34. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
35. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2002;25:1790-1794.
36. Wilson PWF, Grundy SM. The metabolic syndrome: Practical guide to origins and treatment: Part I. Circulation. 2003;108:1422-1425.
37. Grundy SM, Hansen B, Smith SC JR, Cleeman JI, Kahn RA. Clinical management of the metabolic syndrome. Circulation. 2004;109:551-556.
38. Willett WC, Sacks F, Trichopoulou A, et. al. Mediterranean diet pyramid: A cultural model for healthy eating. Am J Clin Nutr. 1995;61:1402S-1406S.
39. Premier Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA. 2003;289:2083-2093.